Delivery Order SPE2DB20D9135-SPE2DB22FD2VG

Award Date 10/21/21
Potential Completion Date 11/12/21
Potential Value $46K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $53,318.24 firm fixed-price delivery order is for the provision of MACI 3CM X 5CM IMPLANT SHEETS, which are medical devices. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which provides a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 firm fixed-price delivery order is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a type of medical implant, with a period of performance through November 4, 2024. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,902.91 firm fixed-price delivery order is for the provision of MACI 3CM X 5CM implant sheets, a medical device product. The award is not associated with a set-aside designation. DMS Pharmaceutical Group holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 award is for the supply of MACI 3CM X 5CM IMPLANT SHEETS, a medical device product, with an ultimate completion date of October 1, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth up to $57,317.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, is for the delivery of 4564741483 MACI 3CM X 5CM Implant Sheets with a completion date of April 25, 2024. This Delivery Order contract is part of a larger Indefinite Delivery Vehicle (IDV) contract, number...
This federal contract award, valued at $57,317.20, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order under the DLA's SPE2DB indefinite delivery contract (IDC), which has a ceiling value of $499,999,999 and is valid through November 2026. The contract is for the delivery of 4566653511 MACI 3cm x 5cm implant sheets, a specialized...
This federal contract award was made by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $57,317.20 firm fixed-price delivery order contract is for the delivery of 4566516778 MACI 3CM X 5CM implant sheets. The contract is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
This federal contract award, valued at $61,902.91, was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order for the supply of 4567903314 MACI 3CM X 5CM IMPLANT SHEETS, a specialized medical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $53,422.99, is for the delivery of MACI 3CM X 5CM implant sheets, which are medical devices used for various surgical procedures. The contract has an ultimate completion date of September 6, 2023 and is a firm fixed-price delivery order. DMS Pharmaceutical Group holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,902.91 firm fixed-price delivery order is for the provision of MACI 3CM X 5CM IMPLANT SHEETS to support the recurring medical supply needs of military healthcare facilities. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
  • SPE2DB20D9135
    Indefinite Delivery Contract
  • SPE2DB20D9135-SPE2DB22FD2VG
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded on October 21, 2021, is a delivery order with a firm fixed price of $46,119.30 and a completion date of November 12, 2021. The contract covers the delivery of MACI 3CM X 5CM implant sheets, which are medical devices used in various medical procedures.

The contract is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical needs of military personnel and their dependents across various Department of Defense healthcare facilities.

Generated 1/9/25, 9:02 AM